Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 5Recruiting 3Not yet recruiting 3Withdrawn 1Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 9OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Ovarian Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × BID protein, human × Clear all
NCT03246074 2024-10-24

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
35 enrolled 16 charts
Gynecologic

Ovarian Neoplasms

NCT01856283 2021-01-13

Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells

Niguarda Hospital

Phase 2 Completed
87 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT00405210 2011-05-23

Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 1 Completed
38 enrolled
Genitourinary

Prostatic Neoplasms

NCT00328432 2008-09-17

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

University of Kansas Medical Center

Phase 1 Completed
100 enrolled
Breast

Breast Neoplasms

NCT00291122 2008-09-16

An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer

University of Kansas Medical Center

Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡